A review: advances of curcumin co-delivery biomaterials-based system in anti-tumor therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, Zhai Z, Tanzhu G, Yang J, Zhou R (2024) Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther 9(1):17010.1038/s41392-024-01851-y ↗
2. Hoang D-T, Dinstag G, Shulman ED, Hermida LC, Ben-Zvi DS, Elis E, Caley K, Sammut S-J, Sinha S, Sinha N, Dampier CH, Stossel C, Patil T, Rajan A, Lassoued W, Strauss J, Bailey S, Allen C, Redman J, Beker T, Jiang P, Golan T, Wilkinson S, Sowalsky AG, Pine SR, Caldas C, Gulley JL, Aldape K, Aharonov R, Stone EA, Ruppin E (2024) A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics. Nature Cancer 5:130510.1038/s43018-024-00793-2 ↗
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–42410.3322/caac.21492 ↗
4. Biondo S, Frago R, Kreisler E (2024) Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma. Ann Oncol: Off J Eur Soc Med Oncol 35:75710.1016/j.annonc.2024.06.017 ↗
5. Dilly J, Hoffman MT, Abbassi L, Li Z, Paradiso F, Parent BD, Hennessey CJ, Jordan AC, Morgado M, Dasgupta S, Uribe GA, Yang A, Kapner KS, Hambitzer FP, Qiang L, Feng H, Geisberg J, Wang J, Evans KE, Lyu H, Schalck A, Feng N, Lopez AM, Bristow CA, Kim MP, Rajapakshe KI, Bahrambeigi V, Roth JA, Garg K, Guerrero PA, Stanger BZ, Cristea S, Lowe SW, Baslan T, Van Allen EM, Mancias JD, Chan E, Anderson A, Katlinskaya YV, Shalek AK, Hong DS, Pant S, Hallin J, Anderes K, Olson P, Heffernan TP, Chugh S, Christensen JG, Maitra A, Wolpin BM, Raghavan S, Nowak JA, Winter PS, Dougan SK, Aguirre AJ (2024) Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer. Cancer Discov 14:213510.1158/2159-8290.CD-24-0177 ↗
6. Bahadar N, Bahadar S, Sajid A, Wahid M, Ali G, Alghamdi A, Zada H, Khan T, Ullah S, Sun Q (2024) Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer. Breast Cancer Res 26(1):11410.1186/s13058-024-01868-9 ↗
7. Wei Z, Li B, Wen X, Jakobsson V, Liu P, Chen X, Zhang J (2024) Engineered antibodies as cancer radiotheranostics. Adv Sci (Weinh) 11:e240236110.1002/advs.202402361 ↗
8. Harris MA, Savas P, Virassamy B, O’Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R, Loi S (2024) Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer 24:55410.1038/s41568-024-00714-6 ↗
9. Iqbal H, Razzaq A, Liu F, Zhang F, Tao J, Li T, Jiang Y, Zhao Z, Qin M, Lin X, Ke H, Chen H, Deng Y (2024) A bioinspired doxorubicin-carried albumin nanocage against aggressive cancer via systemic targeting of tumor and lymph node metastasis. J Control Release 372:829–84510.1016/j.jconrel.2024.07.001 ↗
10. Qin S, Liu Y, Zhang X, Huang P, Xia L, Leng W, Li D (2024) lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1. J Exp Clin Cancer Res 43(1):18810.1186/s13046-024-03103-x ↗
11. Tarantino P, Tayob N, Villacampa G, Dang C, Yardley DA, Isakoff SJ, Valero V, Faggen M, Mulvey T, Bose R, Weckstein D, Wolff AC, Reeder-Hayes K, Rugo HS, Ramaswamy B, Zuckerman D, Hart L, Gadi VK, Constantine M, Cheng K, Garrett AM, Marcom PK, Albain K, DeFusco P, Tung N, Ardman B, Nanda R, Jankowitz RC, Rimawi M, Abramson V, Pohlmann PR, Van Poznak C, Forero-Torres A, Liu MC, Ruddy KJ, Waks AG, DeMeo M, Burstein HJ, Partridge AH, Dell’Orto P, Russo L, Krause E, Newhouse DJ, Kurt BB, Mittendorf EA, Schneider B, Prat A, Winer EP, Krop IE, Tolaney SM (2024) Adjuvant trastuzumab emtansine versus paclitaxel plus trastuzumab for stage I human epidermal growth factor receptor 2-positive breast cancer: 5-year results and correlative analyses from ATEMPT. J Clin Oncol 83:2302170
12. Moon DO (2024) Curcumin in cancer and inflammation: an in-depth exploration of molecular interactions therapeutic potentials, and the role in disease management. Int J Mol Sci 25(5):291110.3390/ijms25052911 ↗
13. Alkahtani S, Al-Johani NS, Alarifi S, Afzal M (2023) Cytotoxicity mechanisms of blue-light-activated curcumin in T98G cell line: inducing apoptosis through ROS-dependent downregulation of MMP pathways. Int J Mol Sci 24(4):384210.3390/ijms24043842 ↗
14. Song L, Zhang W, Tang SY, Luo SM, Xiong PY, Liu JY, Hu HC, Chen YQ, Jia B, Yan QH, Tang SQ, Huang W (2024) Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems. Biomed Pharm = Biomed Pharm 170:11603910.1016/j.biopha.2023.116039 ↗
15. Ravindran F, Mhatre A, Koroth J, Narayan S, Choudhary B (2023) Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells. Life Sci 334:12222410.1016/j.lfs.2023.122224 ↗
16. Choe SR, Kim YN, Park CG, Cho KH, Cho DY, Lee HY (2018) RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin. Exp Mol Med 50(4):1–1010.1038/s12276-018-0078-1 ↗
17. Shao M, Lou D, Yang J, Lin M, Deng X, Fan Q (2020) Curcumin and wikstroflavone B, a new biflavonoid isolated from wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway. Phytomedicine 79:15334110.1016/j.phymed.2020.153341 ↗
18. Banerjee S, Chakravarty AR (2015) Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity. Acc Chem Res 48(7):2075–208310.1021/acs.accounts.5b00127 ↗
19. Han X, Alameh MG, Gong N, Xue L, Ghattas M, Bojja G, Xu J, Zhao G, Warzecha CC, Padilla MS, El-Mayta R, Dwivedi G, Xu Y, Vaughan AE, Wilson JM, Weissman D, Mitchell MJ (2024) Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo. Nat Chem 16:168710.1038/s41557-024-01557-2 ↗
20. Cheong J, Jo A, Lee J, Lee S, Lee J-u, Lee J-H, Lee H, Cheon J (2024) Engineered nanoparticles for clinical assays. Nat Rev Bioeng 2:88710.1038/s44222-024-00208-y ↗
21. Lu P, Ruan D, Huang M, Tian M, Zhu K, Gan Z, Xiao Z (2024) Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. Signal Transduct Target Ther 9(1):16610.1038/s41392-024-01852-x ↗
22. Nele V, Wojciechowski JP, Armstrong JPK, Stevens MM (2020) Tailoring gelation mechanisms for advanced hydrogel applications. Adv Func Mater 30(42):200275910.1002/adfm.202002759 ↗
23. Lei Q, Guo J, Noureddine A, Wang A, Wuttke S, Brinker CJ, Zhu W (2020) Sol–gel-based advanced porous silica materials for biomedical applications. Adv Func Mater 30(41):190953910.1002/adfm.201909539 ↗
24. Khodabukus A, Guyer T, Moore AC, Stevens MM, Guldberg RE, Bursac N (2022) Translating musculoskeletal bioengineering into tissue regeneration therapies. Science Translational Medicine 14(666):eabn907410.1126/scitranslmed.abn9074 ↗
25. Osada K (2014) Development of functional polyplex micelles for systemic gene therapy. Polym J 46(8):469–47510.1038/pj.2014.49 ↗
26. Cai X, Drummond CJ, Zhai J, Tran N (n/a) Lipid nanoparticles: versatile drug delivery vehicles for traversing the blood brain barrier to treat brain cancer, Adv Functional Mater, 2404234
27. Xia J, Ma S, Zhu X, Chen C, Zhang R, Cao Z, Chen X, Zhang L, Zhu Y, Zhang S, Li S, Gu G, Wei X, Yu K, Wang J (2022) Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Science Adv 8(6):eabj126210.1126/sciadv.abj1262 ↗
28. Wang Q, Sheng H, Lv Y, Liang J, Liu Y, Li N, Xie E, Su Q, Ershad F, Lan W, Wang J, Yu C (2022) A skin-mountable hyperthermia patch based on metal nanofiber network with high transparency and low resistivity toward subcutaneous tumor treatment. Adv Func Mater 32(21):211122810.1002/adfm.202111228 ↗
29. Su J, Sun Q, Lin S, Lu S, Zhang Q, Li Y, Li B, Sun Y, Liu K, Zhang H, Wang F, Li J, Wei Y (2022) Biosynthetic and unfolded protein nanocarriers for chemotherapeutic drugs in oral cancers: improved bioavailability and safety of chemotherapeutics. Adv Func Mater 32(45):220427110.1002/adfm.202204271 ↗
30. Tao Y, Chan HF, Shi B, Li M, Leong KW (2020) Light: a magical tool for controlled drug delivery. Adv Func Mater 30(49):200502910.1002/adfm.202005029 ↗
31. Ju X, Kong J, Qi G, Hou S, Diao X, Dong S, Jin Y (2024) A wearable electrostimulation-augmented ionic-gel photothermal patch doped with MXene for skin tumor treatment. Nat Commun 15(1):76210.1038/s41467-024-45070-z ↗
32. Xiang H, Zhao L, Yu L, Chen H, Wei C, Chen Y, Zhao Y (2021) Self-assembled organic nanomedicine enables ultrastable photo-to-heat converting theranostics in the second near-infrared biowindow. Nat Commun 12(1):21810.1038/s41467-020-20566-6 ↗
33. Bubnovskaya L, Belous A, Solopan S, Kovelskaya A, Bovkun L, Podoltsev A, Kondtratenko I, Osinsky S (2014) Magnetic fluid hyperthermia of rodent tumors using manganese perovskite nanoparticles. J Nanoparticles 2014(1):278761
34. Wang Y, Zhang R, Zang P, Zhao R, Wu L, Zhu Y, Yang D, Gai S, Yang P (2024) Synergizing pyroelectric catalysis and enzyme catalysis: establishing a reciprocal and synergistic model to enhance anti-tumor activity. Adv Mater 36(24):e240111110.1002/adma.202401111 ↗
35. Wang C, Li L, Zhang S, Yan Y, Huang Q, Cai X, Xiao J, Cheng Y (2020) Carrier-free platinum nanomedicine for targeted cancer therapy. Small 16(49):e200482910.1002/smll.202004829 ↗
36. Zhao P, Qiu J, Pan C, Tang Y, Chen M, Song H, Yang J, Hao X (2023) Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer. Phytomedicine 114:15481010.1016/j.phymed.2023.154810 ↗
37. Alharbi HM, Alqahtani T, Alamri AH, Kumarasamy V, Subramaniyan V, Babu KS (2023) Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics. Front Pharmacol 14:127620910.3389/fphar.2023.1276209 ↗
38. Shamsnia HS, Roustaei M, Ahmadvand D, Butler AE, Amirlou D, Soltani S, Momtaz S, Jamialahmadi T, Abdolghaffari AH, Sahebkar A (2023) Impact of curcumin on p38 MAPK: therapeutic implications. Inflammopharmacology 31(5):2201–221210.1007/s10787-023-01265-2 ↗
39. Zhou H, Wu Z, Zhang Y, Yu Z, Nie Z, Fan J, Zhu Z, Chen F, Wang T (2024) In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway. Mol Divers 29:7310.1007/s11030-024-10833-9 ↗
40. Nayak D, Paul S, Das C, Bhal S, Kundu CN (2023) Quinacrine and curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A. J Cell Commun Signal 17(3):609–62610.1007/s12079-022-00692-0 ↗
41. Liu Y, Liu Y, Sun X, Wang Y, Du C, Bai J (2024) Morphologically transformable peptide nanocarriers coloaded with doxorubicin and curcumin inhibit the growth and metastasis of hepatocellular carcinoma. Mater Today Bio 24:10090310.1016/j.mtbio.2023.100903 ↗
42. Valiveti CK, Kumar B, Singh AD, Biradar SK, Ahmad R, Singh AB, Tummala H (2024) Stable dietary ora-curcumin formulation protects from experimental colitis and colorectal cancer. Cells 13(11):95710.3390/cells13110957 ↗
43. Rawas-Qalaji M, Jagal J, Sadik S, Said Z, Ahmed IS, Haider M, Hussain Z, Alhalaweh A (2024) Assessment of enhancing curcumin’s solubility versus uptake on its anti-cancer efficacy. Colloids Surf B Biointerfaces 242:11409010.1016/j.colsurfb.2024.114090 ↗
44. Luo X, Zhang M, Dai W, Xiao X, Li X, Zhu Y, Shi X, Li Z (2024) Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation. J Nanobiotechnology 22(1):44010.1186/s12951-024-02652-9 ↗
45. Sun W, Hu S, Wang X (2024) Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies. Cancer Commun (Lond) 44:107110.1002/cac2.12587 ↗
46. Chen L, Nabil A, Fujisawa N, Oe E, Li K, Ebara M (2023) A facile, flexible, and multifunctional thermo-chemotherapy system for customized treatment of drug-resistant breast cancer. J Control Release 363:550–56110.1016/j.jconrel.2023.10.010 ↗
47. Wen ZJ, Wang ZY, Zhang YF (2022) Adverse cardiovascular effects and potential molecular mechanisms of DEHP and its metabolites-a review. Sci Total Environ 847:15744310.1016/j.scitotenv.2022.157443 ↗
48. Hu L, Sun Y, Luo J, He X, Ye M, Li G, Zhang Y, Bai J, Zhang D, Chang C (2020) Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression. Oncogene 39(9):1891–190310.1038/s41388-019-1070-5 ↗
49. Yan J, Wang Y, Jia Y, Liu S, Tian C, Pan W, Liu X, Wang H (2017) Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Biomed Pharmacotherapy = Biomed Pharm 88:374–38310.1016/j.biopha.2016.12.138 ↗
50. Xiao H, Guo Y, Liu H, Liu Y, Wang Y, Li C, Císař J, Škoda D, Kuřitka I, Guo L, Sedlařík V (2020) Structure-based design of charge-conversional drug self-delivery systems for better targeted cancer therapy. Biomaterials 232:11970110.1016/j.biomaterials.2019.119701 ↗
51. Li L, Wang X, Gao S, Zheng S, Zou X, Xiong J, Li W, Yan F (2023) High-toughness and high-strength solvent-free linear poly(ionic liquid) elastomers. Adv Mater 36:e230854710.1002/adma.202308547 ↗
52. Borah A, Pillai SC, Rochani AK, Palaninathan V, Nakajima Y, Maekawa T, Kumar DS (2020) GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma. Nanotechnology 31(18):18510210.1088/1361-6528/ab6d20 ↗
53. Yang Z, Sun N, Cheng R, Zhao C, Liu Z, Li X, Liu J, Tian Z (2017) pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Biomaterials 147:53–6710.1016/j.biomaterials.2017.09.013 ↗
54. Nassar D, Blanpain C (2016) Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol 11:47–7610.1146/annurev-pathol-012615-044438 ↗
55. Clara JA, Monge C, Yang Y, Takebe N (2020) Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol 17(4):204–23210.1038/s41571-019-0293-2 ↗
56. Rong D, Wang C, Zhang X, Wei Y, Zhang M, Liu D, Farhan H, Momen Ali SA, Liu Y, Taouil A, Guo W, Wang Y, Ojima I, Yang S, Wang H (2020) A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells. Cancer Lett 491:36–4910.1016/j.canlet.2020.06.025 ↗
57. Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar GL (2019) Curcumin and solid lipid curcumin particles induce autophagy, but inhibit mitophagy and the PI3K-Akt/mTOR pathway in cultured glioblastoma cells. Int J Mol Sci 20(2):39910.3390/ijms20020399 ↗
58. Li Y, Zhang T (2014) Targeting cancer stem cells by curcumin and clinical applications. Cancer Lett 346(2):197–20510.1016/j.canlet.2014.01.012 ↗
59. Lu J, Song J, Zhang P, Huang Y, Lu X, Dai H, Xi J (2023) Biomineralized polydopamine nanoparticle-based sodium alginate hydrogels for delivery of anti-serine/threonine protein kinase B-rapidly accelerated fibrosarcoma siRNA for metastatic melanoma therapy. ACS Nano 17:1821810.1021/acsnano.3c05563 ↗
60. Qian KY, Song Y, Yan X, Dong L, Xue J, Xu Y, Wang B, Cao B, Hou Q, Peng W, Hu J, Jiang K, Chen S, Wang H, Lu Y (2020) Injectable ferrimagnetic silk fibroin hydrogel for magnetic hyperthermia ablation of deep tumor. Biomaterials 259:12029910.1016/j.biomaterials.2020.120299 ↗
61. Liu Y, Bhattarai P, Dai Z, Chen X (2019) Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev 48(7):2053–210810.1039/C8CS00618K ↗
62. Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, Du Y, Li Q, Lou Y, Qiu Y, You J (2019) Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun 10(1):334910.1038/s41467-019-11269-8 ↗
63. Wei W, Zhang X, Zhang S, Wei G, Su Z (2019) Biomedical and bioactive engineered nanomaterials for targeted tumor photothermal therapy: a review. Mater Sci Eng C Mater Biol Appl 104:10989110.1016/j.msec.2019.109891 ↗
64. Xi Y, Ge J, Wang M, Chen M, Niu W, Cheng W, Xue Y, Lin C, Lei B (2020) Bioactive anti-inflammatory antibacterial, antioxidative silicon-based nanofibrous dressing enables cutaneous tumor photothermo-chemo therapy and infection-induced wound healing. ACS Nano 14(3):2904–291610.1021/acsnano.9b07173 ↗
65. Qu J, Zhao X, Liang Y, Zhang T, Ma PX, Guo B (2018) Antibacterial adhesive injectable hydrogels with rapid self-healing, extensibility and compressibility as wound dressing for joints skin wound healing. Biomaterials 183:185–19910.1016/j.biomaterials.2018.08.044 ↗
66. Alizadeh N, Malakzadeh S (2020) Antioxidant, antibacterial and anti-cancer activities of β-and γ-CDs/curcumin loaded in chitosan nanoparticles. Int J Biol Macromol 147:778–79110.1016/j.ijbiomac.2020.01.206 ↗
67. Yang S, Zhao Z, Xie Y, Lin J, Zhang B, Fan J (2022) Engineering Bio-MOF/polydopamine as a biocompatible targeted theranostic system for synergistic multi-drug chemo-photothermal therapy. Int J Pharm 623:12191210.1016/j.ijpharm.2022.121912 ↗
68. Tan B, Wu Y, Wu Y, Shi K, Han R, Li Y, Qian Z, Liao J (2021) Interfaces, coCurcumin-microsphere/IR820 hybrid bifunctional hydrogels for in situ osteosarcoma chemo-thermal therapy and bone reconstruction. ACS Appl Mater Interfaces 13(27):31542–3155310.1021/acsami.1c08775 ↗
69. Wang L, Wu M, Pan Y, Xie D, Hong C, Li J, Ma X, Xu H, Li H, Chen T, Wu A, Li Q (2023) Sequential targeting biomimetic nano platform for enhanced mild photothermal therapy and chemotherapy of tumor. Comput Struct Biotechnol J 21:2780–279110.1016/j.csbj.2023.04.024 ↗
70. Khodaei A, Jahanmard F, Madaah Hosseini HR, Bagheri R, Dabbagh A, Weinans H, Amin Yavari S (2022) Controlled temperature-mediated curcumin release from magneto-thermal nanocarriers to kill bone tumors. Bioactive Mater 11:107–11710.1016/j.bioactmat.2021.09.028 ↗
71. Yin Y, Jiang H, Wang Y, Zhang L, Sun C, Xie P, Zheng K, Wang S, Yang Q (2023) Self-assembled nanodelivery system with rapamycin and curcumin for combined photo-chemotherapy of breast cancer. Pharmaceutics 15(3):84910.3390/pharmaceutics15030849 ↗
72. Li H, Zhang N, Hao Y, Wang Y, Jia S, Zhang H (2019) Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system in vivo. Drug Delivery 26(1):1017–102610.1080/10717544.2019.1672829 ↗
73. Roos F, Binder K, Rutz J, Maxeiner S, Bernd A, Kippenberger S, Zöller N, Chun FK, Juengel E, Blaheta RA (2019) The antitumor effect of curcumin in urothelial cancer cells is enhanced by light exposure in vitro. Evid-Based Complement Altern Med : eCAM 2019:637494010.1155/2019/6374940 ↗
74. Tan B, Tang Q, Zhong Y, Wei Y, He L, Wu Y, Wu J, Liao J (2021) Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration. Int J Oral Sci 13(1):910.1038/s41368-021-00113-9 ↗
75. Piot-Ziegler C, Sassi ML, Raffoul W, Delaloye JF (2010) Mastectomy, body deconstruction, and impact on identity: a qualitative study. Br J Health Psychol 15(Pt 3):479–51010.1348/135910709X472174 ↗
76. Zwakman M, Tan A, Boersma C, Klinkenbijl JHG, Noorda EM, de Jong TR, Francken AB (2022) Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancer. Eur J Surg Oncol: J Eur Soc Surg Oncol British Assoc Surg Oncol 48(8):1692–169810.1016/j.ejso.2022.02.011 ↗
77. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, O’Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA (2019) Adult cancer pain, version 3.2019 NCCN clinical practice guidelines in oncology. J Nat Comprehensive Cancer Netw: JNCCN 17(8):977–100710.6004/jnccn.2019.0038 ↗
78. Ay C, Beyer-Westendorf J, Pabinger I (2019) Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants. Ann Oncol: Off J Eur Soc Med Oncol 30(6):897–90710.1093/annonc/mdz111 ↗
79. Han R, Min Y, Li G, Chen S, Xie M, Zhao Z (2023) Supercritical CO(2)-assisted fabrication of CM-PDA/SF/nHA nanofibrous scaffolds for bone regeneration and chemo-photothermal therapy against osteosarcoma. Biomaterials science 11(15):5218–523110.1039/D3BM00532A ↗
80. Sánchez-Salcedo S, Heras C, Lozano D, Vallet-Regí M, Salinas AJ (2023) Nanodevices based on mesoporous glass nanoparticles enhanced with zinc and curcumin to fight infection and regenerate bone. Acta Biomater 166:655–66910.1016/j.actbio.2023.04.046 ↗
81. Ji X, Yuan X, Ma L, Bi B, Zhu H, Lei Z, Liu W, Pu H, Jiang J, Jiang X, Zhang Y, Xiao J (2020) Mesenchymal stem cell-loaded thermosensitive hydroxypropyl chitin hydrogel combined with a three-dimensional-printed poly(ε-caprolactone) /nano-hydroxyapatite scaffold to repair bone defects via osteogenesis, angiogenesis and immunomodulation. Theranostics 10(2):725–74010.7150/thno.39167 ↗
82. Mahon OR, Browe DC, Gonzalez-Fernandez T, Pitacco P, Whelan IT, Von Euw S, Hobbs C, Nicolosi V, Cunningham KT, Mills KHG, Kelly DJ, Dunne A (2020) Nano-particle mediated M2 macrophage polarization enhances bone formation and MSC osteogenesis in an IL-10 dependent manner. Biomaterials 239:11983310.1016/j.biomaterials.2020.119833 ↗
83. Amarsy I, Papot S, Gasser G (2022) Stimuli-responsive metal complexes for biomedical applications. Angew Chem Int Ed Engl 61(40):e20220590010.1002/anie.202205900 ↗
84. Ge YX, Zhang TW, Zhou L, Ding W, Liang HF, Hu ZC, Chen Q, Dong J, Xue FF, Yin XF, Jiang LB (2022) Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework. Biomaterials 282:12140710.1016/j.biomaterials.2022.121407 ↗
85. Zhao H, Liu R, Wang L, Tang F, Chen W, Liu YN (2023) Artificial macrophage with hierarchical nanostructure for biomimetic reconstruction of antitumor immunity. Nano-Micro Lett 15(1):21610.1007/s40820-023-01193-4 ↗
86. Yang Y, Zhu Y, Wang K, Miao Y, Zhang Y, Gao J, Qin H, Zhang Y (2023) Activation of autophagy by in situ Zn(2+) chelation reaction for enhanced tumor chemoimmunotherapy. Bioact Mater 29:116–131
87. Zhi S, Zhang X, Zhang J, Wang XY, Bi S (2023) Functional nucleic acids-engineered bio-barcode nanoplatforms for targeted synergistic therapy of multidrug-resistant cancer. ACS Nano 17(14):13533–1354410.1021/acsnano.3c02009 ↗
88. Zhang DY, Huang F, Ma Y, Liang G, Peng Z, Guan S, Zhai J (2021) Tumor microenvironment-responsive theranostic nanoplatform for guided molecular dynamic/photodynamic synergistic therapy. ACS Appl Mater Interfaces 13(15):17392–1740310.1021/acsami.1c03277 ↗
89. Jiang Z, Wang T, Yuan S, Wang M, Qi W, Su R, He Z (2020) A tumor-sensitive biological metal-organic complex for drug delivery and cancer therapy. J Mater Chem B 8(32):7189–719610.1039/D0TB00599A ↗
90. Wang Y, Zhao Y, Ma S, Fu M, Wu M, Li J, Wu K, Zhuang X, Lu Z, Guo J (2023) Injective programmable proanthocyanidin-coordinated zinc-based composite hydrogel for infected bone repair. Adv Healthcare Mater 13:e230269010.1002/adhm.202302690 ↗
91. Wang X, Zhang X, Li N, Yang Z, Li B, Zhang X, Li H (2024) Prioritized regional management for antibiotics and heavy metals in animal manure across China. J Hazard Mater 461:13270610.1016/j.jhazmat.2023.132706 ↗
92. Wang Z, Cai W, Ning F, Sun W, Du J, Long S, Fan J, Chen X, Peng X (2023) DPA-Zn induced targeting and photo-eliminating of pseudomonas aeruginosa and drug-resistance gram-positive bacteria. Adv Healthcare Mater 13:e230249010.1002/adhm.202302490 ↗
93. Gong J, Ye C, Ran J, Xiong X, Fang X, Zhou X, Yi Y, Lu X, Wang J, Xie C, Liu J (2023) Polydopamine-mediated immunomodulatory patch for diabetic periodontal tissue regeneration assisted by metformin-ZIF system. ACS Nano 17(17):16573–1658610.1021/acsnano.3c02407 ↗
94. Zhao Y, Li J, Liu L, Wang Y, Ju Y, Zeng C, Lu Z, Xie D, Guo J (2023) Zinc-based tannin-modified composite microparticulate scaffolds with balanced antimicrobial activity and osteogenesis for infected bone defect repair. Adv Healthcare Mater 12(20):e230030310.1002/adhm.202300303 ↗
95. Wang B, Zeng Y, Liu S, Zhou M, Fang H, Wang Z, Sun J (2023) ZIF-8 induced hydroxyapatite-like crystals enabled superior osteogenic ability of MEW printing PCL scaffolds. J Nanobiotechnology 21(1):26410.1186/s12951-023-02007-w ↗
96. Xu L, Xu S, Xiang TY, Chen LW, Zhong WX, Zhu L, Liu H, Wu L, Li WD, Wang YT, Cai BC, Yao JH, Chen R, Xin WF, Cao G, Chen ZP (2022) A novel peptide hydrogel of metal ion clusters for accelerating bone defect regeneration. J Control Release 353:738–75110.1016/j.jconrel.2022.12.031 ↗
97. Qian Y, Chen W, Wang M, Xie Y, Qiao L, Sun Q, Gao M, Li C (2024) Tumor microenvironment-specific driven nanoagents for synergistic mitochondria damage-related immunogenic cell death and alleviated immunosuppression. Small Methods 8(7):e230123110.1002/smtd.202301231 ↗
98. Bagheri AR, Li C, Zhang X, Zhou X, Aramesh N, Zhou H, Jia J (2021) Recent advances in covalent organic frameworks for cancer diagnosis and therapy. Biomater Sci 9(17):5745–576110.1039/D1BM00960E ↗
99. Singh N, Kim J, Kim J, Lee K, Zunbul Z, Lee I, Kim E, Chi SG, Kim JS (2023) Covalent organic framework nanomedicines: biocompatibility for advanced nanocarriers and cancer theranostics applications. Bioactive Mater 21:358–38010.1016/j.bioactmat.2022.08.016 ↗
100. He X, Jiang Z, Akakuru OU, Li J, Wu A (2021) Nanoscale covalent organic frameworks: from controlled synthesis to cancer therapy. Chem Commun (Camb) 57(93):12417–1243510.1039/D1CC04846E ↗